Literature DB >> 6539440

Oligoclonal bands in CSF: twins with MS.

X H Xu, D E McFarlin.   

Abstract

Oligoclonal bands ( OCBs ) were examined in CSF from 23 normal controls, 8 cases of inflammatory neurologic diseases, 24 cases of noninflammatory neurologic diseases, 27 sporadic cases of MS, and the 29 MS twin pairs, by isoelectric focusing followed by silver staining or western transblotting and immunoperoxidase staining. These methods are sensitive enough to detect as little as 25 ng of IgG. OCBs were detected in the CSF of 34 of 35 twins with clinical evidence of MS and in the CSF of 12 of 17 clinically normal twins. In some of these normal twins, the presence of OCBs in CSF antedated clinical manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539440     DOI: 10.1212/wnl.34.6.769

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Authors:  M E Smith; N L Eller; H F McFarland; M K Racke; C S Raine
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 2.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Mechanisms of action of interferon-beta in multiple sclerosis.

Authors:  B G Arnason; A Dayal; Z X Qu; M A Jensen; K Genç; A T Reder
Journal:  Springer Semin Immunopathol       Date:  1996

4.  British Isles survey of multiple sclerosis in twins: MRI.

Authors:  J W Thorpe; C J Mumford; D A Compston; B E Kendall; D G MacManus; W I McDonald; D H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

Review 5.  The clinical use of cerebrospinal fluid studies in demyelinating neurological diseases.

Authors:  M G Harrington; P G Kennedy
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

6.  Magnetic resonance imaging studies in multiple sclerosis twins.

Authors:  B M Uitdehaag; C H Polman; J Valk; J C Koetsier; C J Lucas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

7.  Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis.

Authors:  Cory Teuscher; Janice Y Bunn; Parley D Fillmore; Russell J Butterfield; James F Zachary; Elizabeth P Blankenhorn
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

8.  Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.

Authors:  J P Salier; R Sesboüé; C Martin-Mondière; M Daveau; P Cesaro; B Cavelier; A Coquerel; L Legrand; J M Goust; J D Degos
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 9.  The pathogenesis of multiple sclerosis. Additional considerations.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.